Human Neurturin Biotinylated Antibody
R&D Systems, part of Bio-Techne | Catalog # BAF387
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Biotin
Antibody Source
Polyclonal Goat IgG
Product Specifications
Immunogen
E. coli-derived recombinant human Neurturin
Ala96-Val197
Accession # Q99748
Ala96-Val197
Accession # Q99748
Specificity
Detects human Neurturin in Western blots. In Western blots, approximately 10% cross-reactivity with recombinant mouse Neurturin is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for Human Neurturin Biotinylated Antibody
Application
Recommended Usage
Western Blot
0.1 µg/mL
Sample: Recombinant Human Neurturin (Catalog # 1297-NE)
Sample: Recombinant Human Neurturin (Catalog # 1297-NE)
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS.
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Neurturin
Neurturin is a member of the GDNF family of ligands and is distantly related to TGF‑ beta family ligands. It is a disulfide linked homodimer that interacts with a receptor complex composed of a high affinity ligand binding component (GFR alpha1 or GFR alpha2) and a common signaling component, cRET. Neurturin promotes the survival of avariety of neurons and possibly other cell types.
Alternate Names
NRTN, NTN
Gene Symbol
NRTN
UniProt
Additional Neurturin Products
Product Documents for Human Neurturin Biotinylated Antibody
Product Specific Notices for Human Neurturin Biotinylated Antibody
For research use only
Loading...
Loading...
Loading...
Loading...